Drug Farm Receives Rare Pediatric Disease Designation from the U.S. FDA for DF-003 to Treat ROSAH Syndrome

Drug Farm, a clinical-stage biopharmaceutical company announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation for the company’s alpha-kinase 1 inhibitor, DF-003, to treat patients with ROSAH Syndrome.